ストックスクリーナーアプリを入手
0.3189
1.30%
0.0041
Collplant Biotechnologies Ltd (CLGN) 最新ニュース
CollPlant Biotechnologies (CLGN) holders buy 1,764,706 shares plus new warrants - Stock Titan
Collplant Biotechnologies Ltd (CLGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Collplant Biotechnologies Ltd - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.305|Chg%:-0.010 - TradingKey
Collplant Biotechnologies Ltd (CLGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Collplant Biotechnologies Ltd (CLGN) Cash Flow - TradingKey
TradingKey - TradingKey
Collplant Biotechnologies Ltd (CLGN) Balance Sheet - TradingKey
CollPlant Biotechnologies Ltd. Revenue Breakdown – NASDAQ:CLGN - TradingView
Collplant Biotechnologies Ltd (CLGN) Institutional Confidence - TradingKey
CollPlant Biotechnologies Market Sentiment - Benzinga
CollPlant Biotechnologies (CLGN) completes $10.4M exempt private securities deal - Stock Titan
CollPlant Biotechnologies (CLGN) files to resell 31M shares from 2026 PIPE - Stock Titan
CollPlant Biotechnologies Ltd SEC Filing (Jul 17, 2026) - Stock Titan
Collplant Biotechnologies Ltd (CLGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CollPlant Biotechnologies files prospectus for 31.047M share offering - scanx.trade
CollPlant Biotechnologies Files Prospectus for Resale of 31 Million Shares - Moomoo
CLGN: Selling Stockholders Plan to Offer 31.05 Million Shares - GuruFocus
CollPlant (CLGN) files F-3 to register 31.05M shares from June 2026 PIPE - Stock Titan
CollPlant Biotechnologies Calls July 29 Extraordinary Meeting to Approve Major Share Capital Increase - The Globe and Mail
CollPlant (NASDAQ: CLGN) targets 500M authorized shares in shareholder vote - Stock Titan
CollPlant Biotechnologies (CLGN) Q4 2025 Earnings: Wider‑Than‑Expected Loss Highlights Pre‑Revenue Challenges - dars.gov.et
CollPlant (Nasdaq: CLGN) raises $2.6M in share and warrant private deal - Stock Titan
CollPlant (CLGN) Secures $2.6 Million in Private Placement Offer - GuruFocus
CollPlant announces $2.6 million private placement By Investing.com - Investing.com Australia
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT - PR Newswire
CollPlant Biotechnologies Ltd. announced that it expects to receive $2.6 million in funding - marketscreener.com
CollPlant Biotechnologies (CLGN) Q4 2025 earnings summary - Quartr
Enterprise value to revenue forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Price to earnings forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Enterprise value to revenue forward of CollPlant Biotechnologies Ltd. – BOATS:CLGN - TradingView
Enterprise value to EBIT forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Price to book forward of CollPlant Biotechnologies Ltd. – NASDAQ:CLGN - TradingView
Price to book forward of CollPlant Biotechnologies Ltd. – BOATS:CLGN - TradingView
Enterprise value to EBITDA forward of CollPlant Biotechnologies Ltd. – BOATS:CLGN - TradingView
Collplant Biotechnologies Ltd (CLGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CollPlant Biotechnologies Ltd Actuals & Estimates (NASDAQ:CLGN) - TradingView
CollPlant Biotechnologies (CLGN) Faces Pressure Near Key SupportKAMA Signal - dars.gov.et
CLGN Technical Analysis & Stock Price Forecast - Intellectia AI
CollPlant Biotechnologies Clings to $0.34 in Low-Volatility ConsolidationRVOL Spike - DonanımHaber
Collplant Biotechnologies Ltd (CLGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Collplant Biotechnologies Ltd (CLGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Collplant Biotechnologies Ltd (CLGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CollPlant Heads Toward Nasdaq Deadline With Stock at 40 Cents - Bez Kabli
CollPlant Biotechnologies (CLGN) Holds Near Support Amidst Modest Downside PressureBear Flag - newsline.com
Deal Dispatch: Fertitta Entertainment Buys Caesars For $17.6 Billion, Arsenal Capital Buys Velcro Brands, Teaneck Surgical Center Bankruptcy - Sahm
CollPlant Biotechnologies Posts Wider Q1 Loss as It Explores Strategic Alternatives and Advances Regenerative Aesthetics Pipeline - The Globe and Mail
CollPlant Biotechnologies (CLGN) Hovers Near Support at $0.38 After Marginal DeclineSuperTrend Flip - DonanımHaber
Deal Dispatch: Fertitta Entertainment Buys Caesars For $17.6 Billion, Arsenal Capital Buys Velcro Brands, Teaneck Surgical Center Bankruptcy - Benzinga
CollPlant (CLGN) Reports Q1 2026 Financials and Strategic Updates - GuruFocus
CollPlant Q1 revenue falls to $73K, initiates strategic review - grafa.com
Collplant Biotechnologies: No Definitive Timetable for Process >CLGN - Moomoo
Collplant Biotechnologies: Initiates Process to Evaluate Strategic Alternatives Aimed at Maximizing Shareholder Value >CLGN - Moomoo
Collplant Biotechnologies 1Q Loss $3.1M >CLGN - Moomoo
COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PR Newswire
1.97%
0.83%
大文字化:
|
ボリューム (24 時間):